Ephrin A2 Antikörper
Kurzübersicht für Ephrin A2 Antikörper (ABIN2139640)
Target
Alle Ephrin A2 (EFNA2) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
- 
    - 
                                            Aufreinigung
- EFNA2 antibody was purified by affinity chromatography.
- 
                                            Immunogen
- EFNA2 antibody was raised in mouse using a full length recombinant protein of human EFNA2 (NP_001396) produced in HEK293T cells, as the immunogen.
- 
                                            Isotyp
- IgG2b
 
- 
                                            
- 
    
- 
    - 
                                            Applikationshinweise
- FC: 1:100, IF: 1:100, IHC: 1:150, WB: 1:2000
- 
                                            Beschränkungen
- Nur für Forschungszwecke einsetzbar
 
- 
                                            
- 
    - 
                                            Format
- Liquid
- 
                                            Konzentration
- Lot specific
- 
                                            Buffer
- In PBS buffer, pH 7.3, containg 1 % BSA, 50 % glycerol and 0.02 % sodium azide.
- 
                                            Konservierungsmittel
- Sodium azide
- 
                                            Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            Handhabung
- Avoid repeated freeze/thaw cycles
- 
                                            Lagerung
- -20 °C
- 
                                            Informationen zur Lagerung
- Store at 4 °C for short term storage. Aliquot and store at -20 °C for long term storage.
 
- 
                                            
- 
    - Ephrin A2 (EFNA2)
- 
                                            Andere Bezeichnung
- EFNA2
 Target
- 
                    
 
                                     
                                     
                                    